CD4+ T cell subsets and Tax expression in HTLV-1 associated diseases

References

• Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415–9.
   PubMed Web of Science ®Google Scholar
• Hlela C, Shepperd S, Khumalo NP, Taylor GP. The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev. 2009;11:205–14.
   PubMed Web of Science ®Google Scholar
• Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007;7:266–81.
   PubMed Web of Science ®Google Scholar
• Macchi B, Grelli S, Matteucci C, D'Elios MM, De Carli M, Favalli C, et al.. Human Th1 and Th2 T-cell clones are equally susceptible to infection and immortalization by human T-lymphotropic virus type I. J Gen Virol. 1998;79 (Pt.10):2469–74.
   Google Scholar
• Fujinami RS. A tax on luxury: HTLV-I infection of CD4+CD25+ Tregs. J Clin Invest. 2005;115:1144–6.
   Web of Science ®Google Scholar
• Jones KS, Petrow-Sadowski C, Huang YK, Bertolette DC, Ruscetti FW. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med. 2008;14:429–36.
   PubMed Web of Science ®Google Scholar
• Rouse BT. Regulatory T cells in health and disease. J Intern Med. 2007;262:78–95.
   PubMed Web of Science ®Google Scholar
• Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol. 2007;7:875–88.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–6.
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10:490–500.
   PubMed Web of Science ®Google Scholar
• Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112:1557–69.
   PubMed Web of Science ®Google Scholar
• Roncarolo MG, Gregori S. Is FOXP3 a bona fide marker for human regulatory T cells? Eur J Immunol. 2008;38:925–7.
   PubMed Web of Science ®Google Scholar
• Toulza F, Nosaka K, Takiguchi M, Pagliuca T, Mitsuya H, Tanaka Y, et al.. FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. Int J Cancer. 2009;125:2375–82.
   Web of Science ®Google Scholar
• Toulza F, Nosaka K, Tanaka Y, Schioppa T, Balkwill F, Taylor GP, et al.. Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol. 2010;185:183–9.
   PubMed Web of Science ®Google Scholar
• Toulza F, Heaps A, Tanaka Y, Taylor GP, Bangham CR. High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood. 2008;111:5047–53.
   PubMed Web of Science ®Google Scholar
• Grassmann R, Aboud M, Jeang KT. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene. 2005;24:5976–85.
   PubMed Web of Science ®Google Scholar
• Marriott SJ, Semmes OJ. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene. 2005;24:5986–95.
   PubMed Web of Science ®Google Scholar
• Li-Weber M, Giaisi M, Chlichlia K, Khazaie K, Krammer PH. Human T cell leukemia virus type I Tax enhances IL-4 gene expression in T cells. Eur J Immunol. 2001;31:2623–32.
   Web of Science ®Google Scholar
• Montes M, Sanchez C, Verdonck K, Lake JE, Gonzalez E, Lopez G, et al.. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis. 2009;3:e456.
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Saito M, Matsumoto W, Usuku K, Tanaka Y, Izumo S, et al.. Different cytokine production in tax expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers. J Infect Dis. 2003;187:1116–25.
   Web of Science ®Google Scholar
• Oh U, Grant C, Griffith C, Fugo K, Takenouchi N, Jacobson S. Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection. J Infect Dis. 2006;193:1557–66.
   Web of Science ®Google Scholar
• Best I, Lopez G, Verdonck K, González E, Tipismana M, Gotuzzo E, et al.. IFN-gamma production in response to Tax 161–233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population. Immunology. 2009;128:e777–86.
   PubMed Web of Science ®Google Scholar
• Lee B, Tanaka Y, Tozawa H. Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I. Tohoku J Exp Med. 1989;157:1–11.
   Web of Science ®Google Scholar
• Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al.. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006;203:1701–11.
   PubMed Web of Science ®Google Scholar
• Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods. 2007;319:41–52.
   PubMed Web of Science ®Google Scholar
• Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, et al.. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 2011;117:3113–22.
   PubMed Web of Science ®Google Scholar
• Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res. 2010;20:4–12.
   PubMed Web of Science ®Google Scholar
• Goncalves DU, Proietti FA, Barbosa-Stancioli EF, Martins ML, Ribas JG, Martins-Filho OA, et al.. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network. Inflamm Allergy Drug Targets. 2008;7:98–107.
   PubMedGoogle Scholar
• Montanheiro PA, Penalva de Oliveira AC, Smid J, Fukumori LM, Olah I, da S Duarte AJ, et al.. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis. Scand J Immunol. 2009;70:403–7.
   PubMed Web of Science ®Google Scholar
• Izumo S. Neuropathology of HTLV-1-associated myelopathy (HAM/TSP). Neuropathology. 2010;30:480–5.
   PubMed Web of Science ®Google Scholar
• Nakamura T. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy. Folia neuropathol. 2009;47:182–94.
   PubMedGoogle Scholar
• Long SA, Buckner JH. CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game. J Immunol. 2011;187:2061–6.
   PubMed Web of Science ®Google Scholar